BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 16565890)

  • 1. Could 2'5'-oligoadenylate synthetase isoforms be biomarkers to differentiate between disease flare and infection in lupus patients? A pilot study.
    Ye S; Guo Q; Tang JP; Yang CD; Shen N; Chen SL
    Clin Rheumatol; 2007 Feb; 26(2):186-90. PubMed ID: 16565890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The correlation of myxovirus resistance 1 and 2'5'-ollgoadenylate synthetase 1 with clinical features of systemic lupus erythematosus].
    Li M; Yang NP; Huang XY; Zhao ZY; Zhang J; Liu XX; Pu XY; Dong JL; Ye Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 40(2):268-71. PubMed ID: 19462904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MALAT1 is involved in type I IFNs-mediated systemic lupus erythematosus by up-regulating OAS2, OAS3, and OASL.
    Gao F; Tan Y; Luo H
    Braz J Med Biol Res; 2020; 53(5):e9292. PubMed ID: 32321151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interferon-inducible genes 2', 5'-ollgoadenylate synthetase-like and tetratricopeptide repeats 2 are correlated with clinical features of patients with systemic lupus erythematosus].
    Zhao ZY; Yang NP; Huang XY; Min L; Liu XX; Zhang J; Ye Y; Shi LJ; Zhong X
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Mar; 41(2):247-51. PubMed ID: 20506645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of interferon-inducible genes as diagnostic biomarker for systemic lupus erythematosus.
    Feng X; Huang J; Liu Y; Xiao L; Wang D; Hua B; Tsao BP; Sun L
    Clin Rheumatol; 2015 Jan; 34(1):71-9. PubMed ID: 25344775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between the 2'-5' oligoadenylate synthetase-like protein p59 OASL and the transcriptional repressor methyl CpG-binding protein 1.
    Andersen JB; Strandbygård DJ; Hartmann R; Justesen J
    Eur J Biochem; 2004 Feb; 271(3):628-36. PubMed ID: 14728690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluating type I interferon-inducible gene expression in patients with systemic lupus erythematosus.].
    Huang J; Li RL; Zhu LN; Sun LY; Feng XB
    Zhonghua Nei Ke Za Zhi; 2010 Jan; 49(1):45-8. PubMed ID: 20356482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of the OASL and OAS1 genes in response to viral infections.
    Melchjorsen J; Kristiansen H; Christiansen R; Rintahaka J; Matikainen S; Paludan SR; Hartmann R
    J Interferon Cytokine Res; 2009 Apr; 29(4):199-207. PubMed ID: 19203244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic structure of the mouse 2',5'-oligoadenylate synthetase gene family.
    Kakuta S; Shibata S; Iwakura Y
    J Interferon Cytokine Res; 2002 Sep; 22(9):981-93. PubMed ID: 12396720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the 2'-5'-oligoadenylate synthetase ubiquitin-like family.
    Eskildsen S; Justesen J; Schierup MH; Hartmann R
    Nucleic Acids Res; 2003 Jun; 31(12):3166-73. PubMed ID: 12799444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinguishing infections vs flares in patients with systemic lupus erythematosus.
    Ospina FE; Echeverri A; Zambrano D; Suso JP; Martínez-Blanco J; Cañas CA; Tobón GJ
    Rheumatology (Oxford); 2017 Apr; 56(suppl_1):i46-i54. PubMed ID: 27744359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct antiviral roles for human 2',5'-oligoadenylate synthetase family members against dengue virus infection.
    Lin RJ; Yu HP; Chang BL; Tang WC; Liao CL; Lin YL
    J Immunol; 2009 Dec; 183(12):8035-43. PubMed ID: 19923450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of mouse 2',5'-oligoadenylate synthetase 1 paralogs.
    Elkhateeb E; Tag-El-Din-Hassan HT; Sasaki N; Torigoe D; Morimatsu M; Agui T
    Infect Genet Evol; 2016 Nov; 45():393-401. PubMed ID: 27663720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mammalian 2'-5' oligoadenylate synthetase gene family: evidence for concerted evolution of paralogous Oas1 genes in Rodentia and Artiodactyla.
    Perelygin AA; Zharkikh AA; Scherbik SV; Brinton MA
    J Mol Evol; 2006 Oct; 63(4):562-76. PubMed ID: 17024523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porcine 2', 5'-oligoadenylate synthetases inhibit Japanese encephalitis virus replication in vitro.
    Zheng S; Zhu D; Lian X; Liu W; Cao R; Chen P
    J Med Virol; 2016 May; 88(5):760-8. PubMed ID: 26437676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2',5'-Oligoadenylate synthetase-like gene highly induced by hepatitis C virus infection in human liver is inhibitory to viral replication in vitro.
    Ishibashi M; Wakita T; Esumi M
    Biochem Biophys Res Commun; 2010 Feb; 392(3):397-402. PubMed ID: 20074559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the OAS Gene Family Is Highly Modulated in Subjects Affected by Juvenile Dermatomyositis, Resembling an Immune Response to a dsRNA Virus Infection.
    Musumeci G; Castrogiovanni P; Barbagallo I; Tibullo D; Sanfilippo C; Nunnari G; Pellicanò GF; Pavone P; Caltabiano R; Di Marco R; Imbesi R; Di Rosa M
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30227596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of duck, goose, and ostrich 2'-5'-oligoadenylate synthetase.
    Tag-El-Din-Hassan HT; Morimatsu M; Agui T
    Infect Genet Evol; 2018 Aug; 62():220-232. PubMed ID: 29715528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Association of OASL and Type I Interferons in the Pathogenesis and Survival of Intracellular Replicating Bacterial Species.
    Leisching G; Wiid I; Baker B
    Front Cell Infect Microbiol; 2017; 7():196. PubMed ID: 28580319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic characterization of OAS1/OAS2/OAS3/OASL in breast cancer.
    Zhang Y; Yu C
    BMC Cancer; 2020 Jun; 20(1):575. PubMed ID: 32560641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.